The global protein expression market is expected to reach USD 4.82 billion in 2029 from USD 3.41 billion in 2024 at a CAGR of ...

A telltale sign of ALS is the buildup of a nucleus-bound gene-expression regulatory protein – TDP-43 – in the cytoplasm of ...

StitchR, a new gene therapy technique, delivers large genes in two parts to treat muscular dystrophies by restoring critical proteins in animal models.

Gene therapy can effectively treat various diseases, but for some debilitating conditions like muscular dystrophies there is ...

Drug resistance to doxorubicin is mediated through the ABCG2 protein by the TMEM158 gene.ABCG2 protein ( ATP-binding cassette sub-family G member. Is an efflux pump protein that actively transports ...

A team of medical researchers at the National Institute on Alcohol Abuse and Alcoholism has identified some of the genes and ...

Neurobiology, Neurodegeneration and Repair Laboratory, National Eye Institute, National Institutes of Health, Bethesda, United States This important study employed multiple orthogonal techniques and ...

By analyzing proteomes and transcriptomes across tissues like the brain, heart, and skin, they uncovered proteins linked to ...

A new technology that delivers two halves of a gene separately could enable gene therapy treatments of muscular dystrophies.

StitchR makes it possible to deliver larger payloads with current vectors, expanding the list of diseases targetable by gene therapies.

Gene therapy for some diseases, including Duchenne muscular dystrophy (DMD), can be tricky because the needed gene is often ...